Medacta Group Valuation
| MEDGF Stock | USD 83.91 0.00 0.00% |
At this time, the firm appears to be fairly valued. Medacta Group SA secures a last-minute Real Value of $83.91 per share. The latest price of the firm is $83.91. Our model forecasts the value of Medacta Group SA from analyzing the firm fundamentals such as Current Valuation of 2.11 B, profit margin of 0.12 %, and Return On Equity of 0.21 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Medacta Group's price fluctuation is very steady at this time. Calculation of the real value of Medacta Group SA is based on 3 months time horizon. Increasing Medacta Group's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Medacta pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Medacta Group SA. Since Medacta Group is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medacta Pink Sheet. However, Medacta Group's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 83.91 | Real 83.91 | Hype 83.91 | Naive 83.91 |
The real value of Medacta Pink Sheet, also known as its intrinsic value, is the underlying worth of Medacta Group SA Company, which is reflected in its stock price. It is based on Medacta Group's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Medacta Group's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Medacta Group SA helps investors to forecast how Medacta pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medacta Group more accurately as focusing exclusively on Medacta Group's fundamentals will not take into account other important factors: About Medacta Group Valuation
The pink sheet valuation mechanism determines Medacta Group's current worth on a weekly basis. Our valuation model uses a comparative analysis of Medacta Group. We calculate exposure to Medacta Group's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medacta Group's related companies.Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland. Medacta Group operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 1421 people.
8 Steps to conduct Medacta Group's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Medacta Group's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Medacta Group's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Medacta Group's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Medacta Group's revenue streams: Identify Medacta Group's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Medacta Group's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Medacta Group's growth potential: Evaluate Medacta Group's management, business model, and growth potential.
- Determine Medacta Group's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Medacta Group's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Medacta Group Growth Indicators
Investing in growth stocks can be very risky. If the company such as Medacta Group does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 20 M | |
| Quarterly Earnings Growth Y O Y | -0.139 | |
| Forward Price Earnings | 22.1239 | |
| Retained Earnings | 192.4 M |
Complementary Tools for Medacta Pink Sheet analysis
When running Medacta Group's price analysis, check to measure Medacta Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medacta Group is operating at the current time. Most of Medacta Group's value examination focuses on studying past and present price action to predict the probability of Medacta Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medacta Group's price. Additionally, you may evaluate how the addition of Medacta Group to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Transaction History View history of all your transactions and understand their impact on performance |